4/17
04:35 pm
rvnc
Form 4 Revance Therapeutics, For: Apr 16 Filed by: Jordan Erica
Low
Report
Form 4 Revance Therapeutics, For: Apr 16 Filed by: Jordan Erica
4/9
01:18 pm
rvnc
Form SC 13G/A Revance Therapeutics, Filed by: JPMORGAN CHASE & CO
Low
Report
Form SC 13G/A Revance Therapeutics, Filed by: JPMORGAN CHASE & CO
3/21
04:10 pm
rvnc
Form DEFA14A Revance Therapeutics,
Medium
Report
Form DEFA14A Revance Therapeutics,
3/21
04:08 pm
rvnc
Form DEF 14A Revance Therapeutics, For: May 01
Medium
Report
Form DEF 14A Revance Therapeutics, For: May 01
3/19
06:46 pm
rvnc
Form 4 Revance Therapeutics, For: Mar 15 Filed by: Sjuts Dustin S
Medium
Report
Form 4 Revance Therapeutics, For: Mar 15 Filed by: Sjuts Dustin S
3/19
06:45 pm
rvnc
Form 4 Revance Therapeutics, For: Mar 15 Filed by: Moxie Dwight
Medium
Report
Form 4 Revance Therapeutics, For: Mar 15 Filed by: Moxie Dwight
3/19
06:44 pm
rvnc
Form 4 Revance Therapeutics, For: Mar 15 Filed by: Schilke Tobin
Medium
Report
Form 4 Revance Therapeutics, For: Mar 15 Filed by: Schilke Tobin
3/19
06:43 pm
rvnc
Form 4 Revance Therapeutics, For: Mar 15 Filed by: Foley Mark J
Low
Report
Form 4 Revance Therapeutics, For: Mar 15 Filed by: Foley Mark J
3/18
06:17 am
rvnc
Form 144 Revance Therapeutics, Filed by: Sjuts Dustin S
High
Report
Form 144 Revance Therapeutics, Filed by: Sjuts Dustin S
3/18
06:14 am
rvnc
Form 144 Revance Therapeutics, Filed by: Schilke Tobin
High
Report
Form 144 Revance Therapeutics, Filed by: Schilke Tobin
3/18
06:10 am
rvnc
Form 144 Revance Therapeutics, Filed by: Moxie Dwight
High
Report
Form 144 Revance Therapeutics, Filed by: Moxie Dwight
3/8
04:33 pm
rvnc
Form 4 Revance Therapeutics, For: Mar 06 Filed by: Foley Mark J
Low
Report
Form 4 Revance Therapeutics, For: Mar 06 Filed by: Foley Mark J
3/5
05:08 pm
rvnc
Form 8-K Revance Therapeutics, For: Mar 04
Low
Report
Form 8-K Revance Therapeutics, For: Mar 04
3/5
05:01 pm
rvnc
Form 424B5 Revance Therapeutics,
Low
Report
Form 424B5 Revance Therapeutics,
3/4
05:35 pm
rvnc
Form 4 Revance Therapeutics, For: Feb 29 Filed by: Sjuts Dustin S
Medium
Report
Form 4 Revance Therapeutics, For: Feb 29 Filed by: Sjuts Dustin S
3/4
05:34 pm
rvnc
Form 4 Revance Therapeutics, For: Feb 29 Filed by: Moxie Dwight
Medium
Report
Form 4 Revance Therapeutics, For: Feb 29 Filed by: Moxie Dwight
3/4
04:45 pm
rvnc
Form 4 Revance Therapeutics, For: Feb 29 Filed by: Schilke Tobin
Medium
Report
Form 4 Revance Therapeutics, For: Feb 29 Filed by: Schilke Tobin
3/4
04:34 pm
rvnc
Form 4 Revance Therapeutics, For: Feb 29 Filed by: Foley Mark J
Medium
Report
Form 4 Revance Therapeutics, For: Feb 29 Filed by: Foley Mark J
3/4
06:40 am
rvnc
Form 424B5 Revance Therapeutics,
Medium
Report
Form 424B5 Revance Therapeutics,
2/29
04:39 pm
rvnc
Form 3 Revance Therapeutics, For: Feb 27 Filed by: Jordan Erica
Low
Report
Form 3 Revance Therapeutics, For: Feb 27 Filed by: Jordan Erica
2/29
04:38 pm
rvnc
Form 3 Revance Therapeutics, For: Feb 27 Filed by: Hollander David
Low
Report
Form 3 Revance Therapeutics, For: Feb 27 Filed by: Hollander David
2/29
06:19 am
rvnc
Form S-8 Revance Therapeutics,
High
Report
Form S-8 Revance Therapeutics,
2/28
06:00 pm
rvnc
Form 10-K Revance Therapeutics, For: Dec 31
High
Report
Form 10-K Revance Therapeutics, For: Dec 31
2/28
04:10 pm
rvnc
Form 8-K Revance Therapeutics, For: Feb 23
High
Report
Form 8-K Revance Therapeutics, For: Feb 23
2/14
04:56 pm
rvnc
Form SC 13G/A Revance Therapeutics, Filed by: Palo Alto Investors LP
Low
Report
Form SC 13G/A Revance Therapeutics, Filed by: Palo Alto Investors LP